House and Senate
Medicare conferees are scrambling to find a solution to the problem
of senior dumping -
which will occur when former employers drop current retirees into
the proposed new government entitlement.
Roughly 10 million
seniors currently lack coverage. It is not too late for Congress to
target those in need without hurting those who are not.
Dumping
Seniors
The Congressional Budget Office still insists that if either the
House or Senate bill becomes law, roughly 4 million seniors who
currently have drug coverage through their former employer would
lose that coverage and be dropped into the new government
entitlement.
Emory University Professor Ken Thorpe, former health care policy
advisor to President Bill Clinton, has made similar estimates.
Both bills create
a universal drug entitlement for all seniors, regardless of income
or need. With the government willing to pick up these prescription
drug costs for all seniors, only contractually bound companies
would be certain to continue offering coverage.
For example, union
contracts expire and must be renegotiated; therefore, all retiree
prescription drug coverage is potentially vulnerable.
Members of the
conference committee know this, and more importantly, the 12
million retirees who depend upon employer-provided drug coverage
are also becoming aware of it.
Hitting the
Taxpayer-Again
Conferees are now toying with the idea of subsidizing companies
that provide retiree drug coverage with billions of taxpayer
dollars in the hope they will continue to offer such coverage.
According to Sen.
Charles Grassley, R-Iowa, the conferees are considering spending
$75 billion to $80 billion in taxpayer dollars. In other words, to
fix the Medicare miscalculation, the conferees are considering
allocating roughly the same amount to prop up the drug entitlement
as they are prepared to spend on reconstruction efforts in Iraq.
Presumably, this spending would be in the form of corporate
subsidies beyond those already contained in the Medicare
legislation.
The conferees are also considering a new system of tax credits for
companies so that "employers…set aside money for retiree
health care."
The bottom line:
Congress is considering paying companies to continue to cover
something they already cover in order to deflect political heat
from seniors who face the loss of trusted benefits. In other words,
Congress made a mistake, and the taxpayers are now expected to pay
for that mistake.
Resurrecting
the Clinton Medicare Policy
In 1999, President Clinton proposed adding prescription drugs to
Medicare in the form of a universal entitlement and ran into the
same problem of corporations facing powerful incentives to start
dumping retirees. Like prominent Republicans on the Senate Finance
Committee today, Clinton then also proposed a new round of
subsidies to companies with retiree drug coverage to discourage
patient dumping.
Under the Clinton
Medicare plan, companies would have received a subsidy that "is up
to the level of one-third of the cost of the Clinton plan proposal
for everyone who is enrolled in an employer-sponsored plan." Interestingly, the
House and Senate conferees are considering paying "companies 28
percent of drug costs incurred by their retirees" as one of the
ways to combat dumping.
Creating a New
Set of Problems. Paying federal subsidies to corporations to
keep them from dumping retirees may not even work. While some
companies would be swayed by the desire to keep employees happy,
improve their public relations, or wishing to have a strong
recruiting tool for future employees, many firms would view this
for what it is: an unprecedented opportunity to unburden themselves
of a huge liability at the expense of the taxpayers.
In 1999, the
Clinton Medicare drug proposal would have caused anywhere from 25
percent to 75 percent of retirees to be dumped out of private
coverage.
Commenting on the Clinton drug entitlement and its employer
subsidies, Dwight Bartlett of the American Academy of Actuaries,
said:
Will that be sufficient to induce employers to
keep their prescription drug coverage for their retirees in place?
I think that's questionable. Frankly, wouldn't you rather have the
government pay 100 percent of the cost than one-third of the cost
if you keep the coverage in place?
Today, the
economic incentives to dump are even more powerful. It is estimated
that General Motors alone could save $150 million per year by
dropping retiree drug coverage. Even if the government
were to pay for 90 percent of that, General Motors would still be
left with a $15 million bill every year. If a company could escape
the entire liability, there is no obvious reason why it would not
take advantage of it. So the offer of a subsidy or a tax credit is
no guarantee of the safety of seniors' private drug coverage.
The proposal for
either special tax breaks or flat-out subsidies raises some
interesting new policy problems. If Congress wants to guarantee
that seniors maintain their current coverage without change or
deterioration, a direct, up-front federal subsidy to the company
for some specified period of time would seem to be the best
alternative. If a given company makes an agreement not to reduce or
eliminate seniors' coverage, it would get that subsidy for some
specified period of time, perhaps a year or two, and the federal
government would police the company's drug benefit package to make
sure that there is no diminution of the benefit as the condition of
the federal subsidy. While a special tax credit would be more
administratively complex, it would engender similar political
dynamics: intense lobbying by either retirees or company officials
for the continuation of the special assistance.
However, in either
case, the enactment of a subsidy or a credit would almost certainly
require a change in the Employment Retirement Income Security Act
of 1974, the law governing self-insured companies. And this would
mean that, for the first time, the government would be in the
business of determining and enforcing a benefit standard for
self-insured firms. This would be a major policy change and would
be a significant step toward federal regulation of the details of
company health insurance provisions.
A Better Solution: Targeting the
Drug Subsidies
Slightly more than 40 million
seniors are on Medicare, and more than three fourths of all seniors
have some form of prescription drug coverage. That leaves roughly 10
million seniors, at most, with no coverage, many of whom are
low-income seniors who do not qualify for Medicaid, which does
cover prescription drugs. These seniors who truly need help could
be easily identified and targeted for help without disrupting the
coverage of others who currently do not need help.
It is not too late
for Congress to correct its current course and help only those in
need without harming those who aren't, disrupting existing
coverage, and creating a new scheme of corporate welfare that costs
taxpayers billions more than they are already expected to pay.